Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.

NCT00215774 is registered in ClinicalTrials.gov with Atrial Fibrillation Network as lead sponsor.

NCT NCT00215774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.
Lead sponsor
Atrial Fibrillation Network
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
March 31, 2011
Enrollment
760 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation